Showing 1 - 1 of 1
Brand drug manufacturers use large numbers of patents directed towards the same products creating "patent thickets" to delay or deter generic drug entry. In this Perspective, Dr. Tu and Dr. Sarpatwari show that over the past two decades drug companies have been increasing the intensity of...
Persistent link: https://www.econbiz.de/10014357009